通过氧气驱动的Clostridium butyricum雾化可以防止耐药细菌性肺炎
Mei-Hua Zhan1, Shuai-Hua Zhan2, Hui-Qiang Han3
1Intensive Care Unit, Hejin Municipal People's Hospital, Shanxi Provincial People's Hospital, Hejin, Yuncheng, 043300, Shanxi, China. beauhua@163.com.
Applied microbiology and biotechnology
|January 24, 2026
概括
与口服囊相比,通过雾化吸入Clostridium butyricum显著减少了耐药细菌肺炎. 这种新的输送方法在预防呼吸道感染方面表现有前途.
科学领域:
- 微生物学 微生物学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细菌性肺炎,特别是耐药菌株,是一个重大的临床挑战.
- 目前医院获得的肺炎的预防策略通常涉及抗生素,有助于抵抗.
- Clostridium butyricum 已经显示出潜在的益生菌和免疫调节作用.
研究的目的:
- 为了比较吸入Clostridium butyricum通过氧驱动雾化与口服C. butyricum囊在预防耐药细菌肺炎方面的疗效.
- 评估吸入C.butyricum对与肺炎相关的临床和微生物学参数的影响.
主要方法:
- 进行了一项随机对照试验,涉及310名患者.
- 参与者接受了吸入的C.butyricum与口服安慰剂或吸入的无菌水与口服C.butyricum.
- 评估了临床结果 (温度,白血球,hs-CRP) 和微生物数据 (唾液培养).
主要成果:
- 肺炎的发病率在吸入C.butyricum组 (1.97%) 与口服组 (46.45%) 相比显著较低.
- 吸入C.butyricum导致临床参数和气管分泌状况明显改善.
- 微生物学分析显示,在吸入组中,致病性细菌殖民的显著减少.
结论:
- 通过氧气驱动的雾化输送的吸入Clostridium butyricum在预防耐药细菌肺炎方面比口服更有效.
- 直接通过呼吸道传递增强了C. butyricum的抗炎和抗菌作用.
- 雾化C.butyricum为预防呼吸道感染提供了一个有希望的策略.
相关概念视频
01:30Pneumonia V: Nursing management and Prevention
3.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.5K
01:30Pneumonia I: Introduction
813
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
813
01:29Pneumonia II: Pathophysiology
2.8K
The pathophysiology of pneumonia involves the following steps:
2.8K
02:59Cancer Prevention
7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.7K
01:33Bacterial Transformation
59.5K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
59.5K
01:28Pneumonia IV: Management
785
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
785